Coverage help, ranked · Updated October 2026
If you'd rather run a brand-name GLP-1 through your plan than pay cash for a compounded vial, you need a provider that will actually fight prior authorization for you. We ranked the field for coverage help, with a cash-pay fallback at the top, because denials happen. CoreAge Rx is a featured partner, and providers we work with may appear first.
The short answer
For genuine coverage help — brand-name access and someone to battle your plan's prior authorization — Gala Health is the strongest of the partners we work with. CoreAge Rx, a featured partner, sits first as a flat, transparent cash-pay option and your fallback if a claim is denied. Weigh a covered brand copay against the compounded price before you commit; here's the math.
CoreAge Rx is a featured partner, and providers we work with may appear first. Scores are our own — the Editors’ Rating is printed on every row so you can check it.
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
One price at every dose: $249 for semaglutide or $299 for tirzepatide month to month, falling to $199 on three months and $129 or $179 on a prepaid year — a reasonable all-doses-included option, if you can live with a pharmacy the marketing never names.
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
The rare program that will write you either a compounded vial or an FDA-approved pen and bill the visit through your insurance, holding one price at every dose. The catch is the calendar: the cheap headline needs a year paid upfront, and every refill needs a video call.
Luvo Health publishes a standing price for every program before asking you for anything, and sells almost everything: semaglutide as an injection at $209 or tablets at $259, tirzepatide at $249, a low-dose microdosing tier at $179, and real FDA-approved Ozempic and Zepbound at $1,299 and $1,399 for anyone who wants the on-label product — all per four weeks, with the first four weeks half price on the main programs. Its LegitScript certification is real — the seal ID returns a live image where an invented one errors — and it commits to not charging you if a clinician decides you aren't eligible. Two things hold it back. It never names the pharmacy that compounds any of this, which is a step behind the providers that do. And its own affiliate program is registered as a peptides and longevity offer that lands on a NAD+ and sermorelin page by default, so the weight-loss side of the business is the part it markets least.
Compounded semaglutide at $99 a month and tirzepatide at $129, flat at every dose with no membership fee — from a company carrying an FDA warning letter issued in June 2026.
A women's-condition clinic that happens to prescribe GLP-1s, rather than a weight-loss program wearing a women's-health skin — an OBGYN and a dietitian on every case, real labs, and an every-other-week check-in for a flat $149 with no commitment. The drug is not in that number, and Allara writes brand pens only.
The closest thing on this masthead to an actual obesity-medicine clinic online — a board-certified physician and a registered dietitian on your case, monthly video visits, and a real effort to run treatment through your insurance. The $299 self-pay fee is for that care team, not the medication.
A nationwide, physician-led program that has shifted from compounded to brand-name medication now that the FDA shortage exemption has ended — a disclosed $149/mo membership plus a separately billed drug cost, honest about the shift even where the number is bigger than it used to look.
The only program on this masthead that bills insurance, which changes the arithmetic more than any discount here. The visit is covered in network or costs $250 self-pay, and the medication is billed separately from $165.90 per four-week supply for injectable semaglutide and $210 for tirzepatide — both the visit fee and a full dose table published, which is what makes the model reviewable at all.
The best-funded option on the board: real brand-name Wegovy and Zepbound access, a dedicated insurance concierge, and an app that rarely breaks — with the catch that the membership fee and the medication cost are always two separate charges, and it doesn't say whether check-ins are video or async.
A year-long metabolic program that treats the medication as one lever and intensive human coaching as the other — a disclosed $199/mo membership with a 3-month minimum, a real 20-minute video visit, and insurance doing most of the work on the medication itself.
Pallas Health is a rare thing in this category: a platform that sells both the inexpensive compounded route and the genuine FDA-approved pens, and is straightforward about the price of each. Compounded semaglutide is $199 every four weeks and tirzepatide $299, while brand Zepbound is $1,069, Ozempic $1,299, and Wegovy and Mounjaro $1,349 each, all cash-pay, and the Foundayo tablet is $499 every four weeks. Its own FAQ answers the question that matters most on a titration schedule — does the price rise with the dose — with a flat no, and the clinician, dose adjustments, check-ins and messaging are all inside the plan price with no membership fee. Two named clinicians are active in the federal NPI registry, the LegitScript seal links back to LegitScript's own records, and no FDA warning letter is attributable to the company. The reservations are specific rather than sweeping — plans renew every four weeks, so a year holds 13 charges, the compounding pharmacy is never named, and insurance is not billed at all.
The one program on this masthead that treats menopause and the postpartum year as clinical facts rather than marketing, wrapped around brand-name pens and an insurance coordinator who makes the calls. Then it sells you a year you cannot leave.
Starts at $189/mo for semaglutide or $199/mo for tirzepatide, $40 less on your first order, and scales up with your dose to $299–$389/mo at the top tier. A $199 oral tablet and brand-name Wegovy and Zepbound are also available, in 48 states (all but AL and MS), with a cancel-or-pause-anytime policy.
The rare compounded program that names its doctors and puts a real 30-minute video visit in front of the prescription — and then prices itself in two pieces, so the $60 on the front page is well under half what leaves your account once the $79 clinic fee is added.
FDA warning letters dated 9 September 2025, over the compounded-semaglutide business it has since left behind. Through the Hers front door, a mass-market brand now selling FDA-approved brand-name GLP-1s — Wegovy, Zepbound, Ozempic — instead of the compounded semaglutide it used to. The posted price is only half the bill: a required $149/mo membership sits on top of whatever the medication costs, so the real monthly number is roughly double what the landing page shows.
Maven Clinic built its name on maternity, fertility and menopause care sold through employers, and its new self-pay GLP-1 program brings that women's-health depth to weight care. You pay a $150 monthly membership ($39 the first month) for unlimited clinician support, a nutrition coach and a strength coach, plus FDA-approved medication billed by the pharmacy — about $299 a month all-in for the Wegovy pill and $449 for starting-dose Zepbound. Every dose has a published price, which is rare, but the two-charge structure makes it one of the pricier ways to start.
Midlife-focused weight care with physician messaging and both compounded and FDA-approved brand options. Add the required $99 monthly care fee: compounded semaglutide starts at $169 all-in and tirzepatide at $199. These are starting figures, not a published maintenance-dose ladder. Compounds are unavailable in six states and DC.
One of the few programs that shows both prices at once and says which is which: $149 a month with no commitment, $59 on a twelve-month plan, with the saving printed alongside.
Real GLP-1 starting prices on its products page, no consult required — compounded semaglutide from $199, tirzepatide from $349, oral tablets and three brand pens — plus a $100 credit on the first order, but all sales are final once you pay.
For a family trying to budget, AskRx does something almost nobody else on this page does: it separates the two things you are paying for and shows you both. Its care fee is $90 a month for the physician visit plus $10 a month fulfillment — $100 total, stated in its own footnote — and the medication is billed separately, dispensed through AskRx's own pharmacy and, per the site, 'at cost, never a markup'. Compare that with a single blended monthly figure, where the medication margin is real but invisible, and the transparency is genuinely worth something. It prescribes FDA-approved products only and says so plainly — 'No compounded meds' — which means the Wegovy pen, the Wegovy pill, Zepbound as a pen or KwikPen, and Foundayo, the newer daily GLP-1 pill (orforglipron). Two honest caveats for a family spreadsheet. The $100 is a floor, not a total: no medication price is published anywhere, so what you actually pay each month depends on the drug and on your coverage. And this is not comparable to the $79-$149 compounded memberships elsewhere on this page — those are compounded formulations, these are the manufacturer's finished products, and the gap in price reflects a real difference in what arrives.
Founded by named former clinic owners, with no consultation or membership fees, 24/7 messaging and Zofran offered proactively for nausea — $155/mo semaglutide or $229/mo tirzepatide at any dose, published on a clear pricing page, though only its pharmacy's licensing (not Bodi Envi's own) is confirmed in all 50 states.
The women's-health platform a lot of mothers already have an account with, extended to weight management — and priced as care rather than medication. The $79-plus-$79 is honest and modest; the four-figure retail pen it does not include is not.
One of the only programs on our list offering both molecules as an injection AND a needle-free oral tablet, in all 50 states — but its $179/mo semaglutide headline is a stated summer promo, not a locked-in rate, and its "15-22% weight loss" claim is self-reported customer data, not a clinical trial.
| # | Provider | From | States | Rating |
|---|---|---|---|---|
| 1 | CoreAge Rx | $99/mo | All 50 states | 94 · A |
| 2 | Gala Health | $249/4 wk | All 50 states | 82 · B− |
| 3 | Sesame | See review | All 50 states | 80 · B− |
| 4 | Found | $289/4 wk | See review | 76 · C |
| 5 | Luvo Health | $209/4 wk | See review | 73 · C |
| 6 | Eden | $99/mo | All 50 states | 70 · C |
| 7 | Allara Health | See review | 45 states | 83 · B |
| 8 | Form Health | See review | See review | 81 · B− |
| 9 | LifeMD | See review | All 50 states | 80 · B− |
| 10 | Midi Health | $165.9/4 wk | All 50 states | 80 · B− |
| 11 | Ro | See review | All 50 states | 80 · B− |
| 12 | Calibrate | See review | See review | 79 · C |
| 13 | Pallas Health | $199/4 wk | All 50 states | 78 · C |
| 14 | WeightWatchers Clinic | See review | See review | 78 · C |
| 15 | WePeptideRx | $189/mo | 48 states | 78 · C |
| 16 | Mochi Health | $139/mo | All 50 states | 77 · C |
| 17 | Hims & Hers | See review | All 50 states | 76 · C |
| 18 | Maven Clinic | See review | See review | 74 · C |
| 19 | Alloy | $169/mo | See review | 73 · C |
| 20 | Science & Co | $149/mo | All 50 states | 73 · C |
| 21 | SynergyRx | $199/mo | All 50 states | 72 · C |
| 22 | AskRx | See review | All 50 states | 70 · C |
| 23 | Bodi Envi | $155/mo | All 50 states | 70 · C |
| 24 | Nurx | See review | See review | 70 · C |
| 25 | OnlyRx | $179/mo | All 50 states | 70 · C |
For real coverage help — prescribing brand-name Wegovy or Zepbound and fighting your plan's prior authorization — Gala Health is the strongest of the partners we work with. CoreAge Rx, a featured partner, is shown first as a flat cash-pay option and a fallback if your claim is denied. Providers we work with may appear first.
It varies a lot. Many plans cover GLP-1 medicines for type 2 diabetes but restrict or exclude them for weight management, often behind prior authorization and step therapy. Coverage depends on your specific plan and employer, so a provider that navigates prior authorization for you is worth real points here.
A good provider will appeal and document medical necessity — but denials are common, so it helps to have a cash-pay plan B. A flat, transparent compounded program makes a good plan B: if coverage falls through, you already know the number you'd pay instead.
It can be. Cash-pay brand pricing is high, but if your plan covers a brand GLP-1, your copay can land below a compounded vial's monthly price. Price both — your covered brand copay and the compounded cash price — before you decide.
No coverage at all? See the cheapest GLP-1 without insurance. New to all of this? Start with the best GLP-1 for first-timers or the full 2026 guide for moms. Rankings follow our methodology; coverage varies by plan, so confirm benefits directly. Not medical advice.
Keep exploring
Each board answers a different mother's situation. CoreAge Rx is a featured partner, and providers we work with may appear first.